Type
Dores M, Toledo C. De lepra à hanseníase: Uma análise lexicológica de base sócio-histórica. Diacrítica [Internet]. 2018;32(1):179-208. Available from: http://diacritica.ilch.uminho.pt/index.php/dia/article/view/124/35
Type
Deora MS, Kushwaha AS. Clinico-Pathological Profile of Leprosy Cases in an Institutional Setting. International journal of pharmacy & pharmaceutial research [Internet]. 2018;11(3):83-88. Available from: https://tinyurl.com/y8gtcuhj
Type
Verjee M. Leprosy: A Time for Elimination by 2020. Clinical infectious diseases [Internet]. 2018;2(2):3. Available from: https://tinyurl.com/y7dckd6c
Type
Ibikunle PO, Obi CS. Stability (test-retest) reliability, concurrent, convergent and divergent validity of the Igbo version of participation scale (I-Pscale) among people living with Hansen’s disease in South-east Nigeria. Leprosy review [Internet]. 2018;89(3):231–241. Available from: https://leprosyreview.org/article/89/3/23-1241
Type
Ibikunle PO, Nwokeji SC. Assessment of stigma among people living with Hansen’s disease in south-east Nigeria. Leprosy review [Internet]. 2017;88(1):43-57. Available from: https://leprosyreview.org/article/88/1/04-3057
Type
Cleary L, Suraj S, Haburchak D, Turrentine J. The armadillo factor: lepromatous leprosy. The American journal of medicine. 2017;.
Type
Cassirer-Costa F, Medeiros N, Chaves A, Lyon S, Coelho-Dos-Reis J, Ribeiro-Junior A, et al. Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients. Cytokine. 2017;97:42-48.
Type
Naik R, Sa DK, Kishori PM. Diagnostic utility of fine needle aspiration cytology of sensory cutaneous nerve in leprosy. Annals of pathology and laboratory medicine [Internet]. 2017;4(2):157-162. Available from: http://www.pacificejournals.com/journal/index.php/apalm/article/view/1178/pdf_345
Type
Franco-Paredes C, Rodríguez-Morales A. Unsolved matters in leprosy: a descriptive review and call for further research. Annals of clinical microbiology and antimicrobials [Internet]. 2016;15(1):33. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875741/pdf/12941_2016_Article_149.pdf
Type
Duthie MS, Balagon M. Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy. Risk management and healthcare policy [Internet]. 2016;9:43-53. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854245/pdf/rmhp-9-043.pdf